[A case of pulmonary alveolar proteinosis associated with pulmonary tuberculosis]. 1984

T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada

UI MeSH Term Description Entries
D007507 Therapeutic Irrigation The washing of a body cavity or surface by flowing water or solution for therapy or diagnosis. Douching,Lavage,Douchings,Irrigation, Therapeutic,Irrigations, Therapeutic,Lavages,Therapeutic Irrigations
D011649 Pulmonary Alveolar Proteinosis A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR. Alveolar Proteinoses, Pulmonary,Alveolar Proteinosis, Pulmonary,Proteinoses, Pulmonary Alveolar,Proteinosis, Pulmonary Alveolar,Pulmonary Alveolar Proteinoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
June 2021, World journal of clinical cases,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
January 2012, Respiratory medicine case reports,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
November 2003, European journal of internal medicine,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
September 2012, Chinese medical journal,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
January 1999, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
April 1971, Chest,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
March 1967, The American review of respiratory disease,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
January 1986, Terapevticheskii arkhiv,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
November 1960, Acta pathologica japonica,
T Shido, and T Mochizuki, and K Inui, and K Reshad, and H Wada
March 1969, Archives of pathology,
Copied contents to your clipboard!